Related Experiment Video
Updated: Aug 29, 2025
06:29
Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
Published on: July 30, 2020
3.2K
Predicting AURKA as a novel therapeutic target for NPC: A comprehensive analysis based on bioinformatics and
Chaobin Huang1, Lin Chen2, Yiping Zhang2
1Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Frontiers in Genetics
|September 8, 2022
Summary
Aurora kinase A (AURKA) is highly expressed in nasopharyngeal carcinoma (NPC), promoting cancer. Targeting AURKA shows potential for new NPC therapies.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Nasopharyngeal carcinoma (NPC) remains a significant health challenge.
- The role of Aurora kinase A (AURKA) in NPC pathogenesis requires comprehensive investigation.
Purpose of the Study:
- To elucidate the clinical function of AURKA in NPC.
- To evaluate AURKA as a potential therapeutic target for NPC.
Main Methods:
- Utilized bioinformatics databases (GEO, STRING, GTEx, CellMiner) for data analysis.
- Performed differential expression, WCGNA, GO, KEGG, GSEA, GSVA, and network analyses.
- Validated AURKA expression via qRT-PCR in NPC tissues.
Main Results:
- AURKA was significantly upregulated in NPC tissues.
- Enrichment analyses implicated AURKA in cell cycle and p53 signaling pathways.
- Identified correlations between AURKA expression, immune cell infiltration, and drug sensitivity (e.g., dacarbazine, vorinostat).
Conclusions:
- AURKA exhibits an oncogenic role in NPC.
- AURKA represents a promising novel therapeutic target for nasopharyngeal carcinoma.
